SOPHiA GENETICS SA

NasdaqGS SOPH

SOPHiA GENETICS SA Revenue for the year ending December 31, 2023: USD 62.37 M

SOPHiA GENETICS SA Revenue is USD 62.37 M for the year ending December 31, 2023, a 31.14% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

SOPHiA GENETICS SA Revenue for the year ending December 31, 2022 was USD 47.56 M, a 17.58% change year over year.
SOPHiA GENETICS SA Revenue for the year ending December 31, 2021 was USD 40.45 M, a 42.43% change year over year.
SOPHiA GENETICS SA Revenue for the year ending December 31, 2020 was USD 28.40 M, a 11.98% change year over year.
SOPHiA GENETICS SA Revenue for the year ending December 31, 2019 was USD 25.36 M.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

NasdaqGS: SOPH

SOPHiA GENETICS SA

CEO	Dr. Jurgi Camblong M.B.A., Ph.D.
IPO Date	July 23, 2021
Location	Switzerland
Headquarters	Rue du Centre 172
Employees	430
Sector	Technology
Industries Software-as-a-Service (SaaS) Telehealth

Description

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

Key trends

Past 5 years